Enhancement of 5-HT1B and 5-HT1D receptor antagonist effects on extracellular 5-HT levels in the guinea-pig brain following concurrent 5-HT1A or 5-HT re-uptake site blockade

被引:29
|
作者
Roberts, C [1 ]
Boyd, DF [1 ]
Middlemiss, DN [1 ]
Routledge, C [1 ]
机构
[1] SmithKline Beecham Pharmaceut, Dept Neurosci, Harlow CM19 5AW, Essex, England
关键词
microdialysis; guinea-pig; 5-HT1B/1D; 5-HT1A; receptor antagonists;
D O I
10.1016/S0028-3908(99)00051-9
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The effects of selective serotonin re-uptake inhibitor (SSRI), paroxetine, and 5-HT1A, 5-HT1B and 5-HT1B/1D receptor antagonists on in vivo extracellular 5-HT levels in the guinea-pig frontal cortex and dorsal hippocampus were investigated using the technique of microdialysis, The aim of the study was to further investigate the autoreceptor roles of the 5-HT1A, 5-HT1B and 5-HT1D receptors in the median vs dorsal raphe nuclei. In the frontal cortex, 5-HT1A (WAY 100635, 1 mg/kg i.p.) or 5-HT1B (SB-224289, 4 mg/kg i.p.) receptor antagonists had no effect on extracellular levels of 5-HT, whilst the mixed 5-HT1B/1D receptor antagonist (GR 127935, 0.3 mg/kg i.p) produced a significant decrease in extracellular 5-HT levels. Paroxetine (10 mu M) significantly increased extracellular 5-HT levels when perfused locally into the cortex. Administration of 3B-224289, followed 120 min later by WAY 100635, had no effect on extracellular 5-HT levels. In contrast, sequential administration of either WAY 100635 and GR 127935, or SB-224289 and paroxetine significantly increased extracellular 5-HT levels. In the dorsal hippocampus, whilst 5-HT1A receptor antagonism elicited by administration of WAY 100635 had no effect, both 5-HT1B and mixed 5-HT1B/1D receptor blockade significantly increased extracellular 5-HT levels. Administration of SE-224289 followed 120 min later with WAY 100635, or WAY 100635 followed 30 min later with GR 127935, potentiated the effect of the three compounds alone, significantly increasing extracellular 5-HT levels. These data demonstrate that to simultaneously increase extracellular 5-HT in both frontal cortex and dorsal hippocampus of the guinea-pig brain concurrent 5-HT1A, 5-HT1B and 5-HT1D receptor blockade is required. Whereas in the dorsal hippocampus, 5-HT1B receptor blockade is sufficient to elicit an increase in extracellular 5-HT levels. (C) 1999 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1409 / 1419
页数:11
相关论文
共 50 条
  • [1] 5-HT1A receptor antagonism or uptake inhibition enhance the effects of 5-HT1B/1D autoreceptor blockade on extracellular 5-HT in guinea-pig forebrain
    Roberts, C
    Boyd, DF
    Price, GW
    Middlemiss, DN
    Routledge, C
    BRITISH JOURNAL OF PHARMACOLOGY, 1998, 125
  • [2] THE EFFECTS OF GR127935, A PUTATIVE 5-HT1D RECEPTOR ANTAGONIST, ON BRAIN 5-HT METABOLISM, EXTRACELLULAR 5-HT CONCENTRATION AND BEHAVIOR IN THE GUINEA-PIG
    HUTSON, PH
    BRISTOW, LJ
    CUNNINGHAM, JR
    HOGG, JE
    LONGMORE, J
    MURRAY, F
    PEARCE, D
    RAZZAQUE, Z
    SAYWELL, K
    TRICKLEBANK, MD
    YOUNG, L
    NEUROPHARMACOLOGY, 1995, 34 (04) : 383 - 392
  • [3] Synergism between 5-HT1B/1D and 5-HT1A receptor antagonists on turnover and release of 5-HT in guinea-pig brain in vivo
    Stenfors, C
    Magnusson, T
    Larsson, LG
    Yu, H
    Hållbus, M
    Magnusson, O
    Ross, SB
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1999, 359 (02) : 110 - 116
  • [4] Synergism between 5-HT1B/1D and 5-HT1A receptor antagonists on turnover and release of 5-HT in guinea-pig brain in vivo
    C. Stenfors
    Teresa Magnusson
    Lars-Gunnar Larsson
    H. Yu
    Marie Hållbus
    O. Magnusson
    Svante B. Ross
    Naunyn-Schmiedeberg's Archives of Pharmacology, 1999, 359 : 110 - 116
  • [5] 5-HT1D AS WELL AS 5-HT1A AUTORECEPTORS MODULATE 5-HT RELEASE IN THE GUINEA-PIG DORSAL RAPHE NUCLEUS
    STARKEY, SJ
    SKINGLE, M
    NEUROPHARMACOLOGY, 1994, 33 (3-4) : 393 - 402
  • [6] 5-HT turnover -: the effects of 5-HT1A and 5-HT transporter genotypes
    Armstrong, J.
    Jenkins, T. A.
    Reynolds, G. P.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2008, 22 : 120 - 120
  • [7] SB-649915, a novel, potent 5-HT1A and 5-HT1B autoreceptor antagonist and 5-HT re-uptake inhibitor in native tissue
    Scott, C
    Soffin, EM
    Hill, M
    Atkinson, PJ
    Langmead, CJ
    Wren, PB
    Faedo, S
    Gordon, LJ
    Price, GW
    Bromidge, S
    Johnson, CN
    Hagan, JJ
    Watson, J
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2006, 536 (1-2) : 54 - 61
  • [8] THE 5-HT TERMINAL AUTORECEPTOR IS A 5-HT1D RECEPTOR SUBTYPE IN THE GUINEA-PIG CORTEX
    ROBERTS, C
    WATSON, J
    BURTON, M
    PRICE, GW
    MULHOLLAND, K
    MIDDLEMISS, DN
    JONES, BJ
    BRITISH JOURNAL OF PHARMACOLOGY, 1994, 112 : U113 - U113
  • [9] Effects of 5-HT1B/1D-and 5-HT1A antagonists on 5-HT release and turnover in the CNS
    Rex, A
    Voigt, JP
    Wicke, KM
    Fink, H
    PHARMACOPSYCHIATRY, 2005, 38 (05) : 271 - 271
  • [10] Effect of a selective 5-HT reuptake inhibitor in combination with 5-HT1A and 5-HT1B receptor antagonists on extracellular 5-HT in rat frontal cortex in vivo
    Sharp, T
    Umbers, V
    Gartside, SE
    BRITISH JOURNAL OF PHARMACOLOGY, 1997, 121 (05) : 941 - 946